» Articles » PMID: 39893562

Complement 3 and 4 Impact in Osteoarthritis

Overview
Journal Biomark Med
Date 2025 Feb 2
PMID 39893562
Authors
Affiliations
Soon will be listed here.
Abstract

To investigate the association between serum complement 3 and 4 (C3 and C4) levels and clinical characteristics in osteoarthritis (OA) patients. This retrospective study included 361 OA patients divided into groups based on complement levels. Clinical data and laboratory test results, including C3, C4, ESR and CRP levels, were analyzed using non-parametric tests, Spearman correlation and multivariate regression. The AC-OA group had lower PA, C3, C4, ESR, CRP and IgA levels compared with controls. C3 levels were positively correlated with ESR (r = 0.260,  < 0.001) and CRP (r = 0.243,  < 0.001). C4 levels also correlated with ESR (r = 0.175,  = 0.001) and CRP (r = 0.263,  < 0.001) and were significantly associated with the number of affected joints. Serum C4 levels are effective indicators of disease activity in OA, particularly in terms of joint involvement and CRP levels, while C3 levels showed no significant association. These findings suggest a potential role for C4 in predicting OA activity.

References
1.
Jariwala M, Laxer R . NETosis in Rheumatic Diseases. Curr Rheumatol Rep. 2021; 23(2):9. DOI: 10.1007/s11926-020-00977-6. View

2.
Nemati D, Quintero D, Best T, Kaushal N . Investigating the association between knee osteoarthritis symptoms with pain catastrophizing domains between Hispanics and non-Hispanic Whites. Rheumatol Int. 2023; 44(11):2539-2546. DOI: 10.1007/s00296-023-05396-1. View

3.
DellIsola A, Vinblad J, Lohmander S, Svensson RN PhD A, Turkiewicz A, Franzen S . Understanding the role of diabetes in the osteoarthritis disease and treatment process: a study protocol for the Swedish Osteoarthritis and Diabetes (SOAD) cohort. BMJ Open. 2019; 9(12):e032923. PMC: 6937096. DOI: 10.1136/bmjopen-2019-032923. View

4.
Russell J, Francis L, Russell N, Osborn S, Dennison S . DEVELOPMENT OF A MOBILITY ASSESSMENT SCORE FOR EVALUATION OF THE EFFECTS OF ORAL HYALURONIC ACID ON CLINICAL LAMENESS IN ASIAN SMALL-CLAWED OTTERS () AND AFRICAN SPOT-NECKED OTTERS () UNDER HUMAN CARE. J Zoo Wildl Med. 2022; 53(2):275-283. DOI: 10.1638/2021-0062. View

5.
Noris M . The case of complement inhibitors. Adv Biol Regul. 2021; 81:100822. PMC: 8375248. DOI: 10.1016/j.jbior.2021.100822. View